Objectives-To investigate whether apoptosis occurs in the synovium of rheumatoid arthritis (RA), and the intermediate molecules operating in this process. Methods-DNA fragmentation was detected by in situ nick end labelling (ISNEL) in the synovium ofpatients with RA (n = 11) and control patients with femoral neck fracture (n = 5). The expression of proteins p53, p21WAF1/CIP1, c-myc, proliferating cell nuclear antigen (PCNA), and Bcl-2 was also examined by immunohistochemistry. Results-ISNEL positive synovial cells with apoptosis specific morphology were detected in extremely limited areas in only two RA synovial tissue specimens. Proteins p53, p2lWAFl'cPl, and c-myc, known inducers ofapoptosis or cell cycle arrest or both, were expressed in the sublining cells independent of ISNEL positive cells. PCNA, a marker for cell proliferation, was observed in the synovial lining cells. Bcl-2, an inhibitor of apoptosis, was expressed mainly in infiltrated lymphocytes and in parts of the sublining layer cells of RA; it also did not correspond with ISNEL staining. Conclusions-Our findings indicate that RA synovial cells undergo apoptosis in addition to cell proliferation, but the frequency of apoptosis was very low. We suspect that the apoptotic process in the RA synovium may be suppressed by overexpression of Bcl-2. Although expressed proteins p53, p21WAFl'CIP1, and c-myc were present in the RA synovium, these protooncogenes are probably not implicated in the apoptotic process. (Ann Rheum Dis 1996; 55: 442-449) Apoptosis, or programmed cell death, is a fundamental process that occurs during morphogenesis and development of the immune system.' 2 Although the mechanism of apoptosis is still unclear, the process proceeds through the activation of an intrinsic cell suicide programme and exhibits specific morphology distinct from that associated with accidental cell death. However, synovial cell death does seem to occur during the natural history of RA, counteracting cell proliferation: the synovial fluid often contains rice bodies, which are thought to be derived from the synovial tissue as a result of cell death." 12 Moreover, during the late stage of the disease, the proliferated synovial tissue is replaced by connective tissue.'3 This suggests that apoptosis may also be involved in synovial cell death and in preventing the development of malignancy despite the neoplastic behaviour of synovial cells.
nuclear antigen (PCNA), and Bcl-2 was also examined by immunohistochemistry. Results-ISNEL positive synovial cells with apoptosis specific morphology were detected in extremely limited areas in only two RA synovial tissue specimens. Proteins p53, p2lWAFl'cPl, and c-myc, known inducers ofapoptosis or cell cycle arrest or both, were expressed in the sublining cells independent of ISNEL positive cells. PCNA, a marker for cell proliferation, was observed in the synovial lining cells. Bcl-2, an inhibitor of apoptosis, was expressed mainly in infiltrated lymphocytes and in parts of the sublining layer cells of RA; it also did not correspond with ISNEL staining. Conclusions-Our findings indicate that RA synovial cells undergo apoptosis in addition to cell proliferation, but the frequency of apoptosis was very low. We suspect that the apoptotic process in the RA synovium may be suppressed by overexpression of Bcl-2. Although expressed proteins p53, p21WAFl'CIP1, and c-myc were present in the RA synovium, these protooncogenes are probably not implicated in the apoptotic process. Apoptosis, or programmed cell death, is a fundamental process that occurs during morphogenesis and development of the immune system.' 2 Although the mechanism of apoptosis is still unclear, the process proceeds through the activation of an intrinsic cell suicide programme and exhibits specific morphology distinct from that associated with accidental cell death. 3 It is now widely accepted that aberrant activation of apoptosis is the aetiological basis or one of the mechanisms of the progression of a variety of human diseases, including the development of cancer, autoimmune disorders, ischaemic injury, and degenerative diseases. 6 7 Abnormal proliferation of synovial cells is an important event in the pathophysiology of rheumatoid arthritis (RA). During the acute phase of RA, the synovial cells grow rapidly, with progressive accumulation of proliferated cells. 8 They also express various proto-oncogenes, such as c-myc, erb, and src, and frequently invade the cartilage tissue.9 10 These features resemble those of preneoplastic conditions, and suggest that dysregulation of the apoptotic machinery plays a role in the pathogenesis of RA: loss of the negative cell cycle control normally provided by apoptosis may initiate abnormal proliferation of synovial cells. However, synovial cell death does seem to occur during the natural history of RA, counteracting cell proliferation: the synovial fluid often contains rice bodies, which are thought to be derived from the synovial tissue as a result of cell death." 12 Moreover, during the late stage of the disease, the proliferated synovial tissue is replaced by connective tissue. '3 This suggests that apoptosis may also be involved in synovial cell death and in preventing the development of malignancy despite the neoplastic behaviour of synovial cells.
To investigate whether apoptosis occurs in the synovium of RA, we studied DNA fragmentation by the in situ nick end labelling (ISNEL) method. We also used immunohistochemical techniques to examine proteins related to apoptosis or cell cycle arrest to investigate the state of synovial cells with respect to apoptosis.
Patients and methods

PATIENTS AND TISSUES
Informed consent was obtained from each patient. Synovial tissue samples were obtained from 11 patients with RA at the time of joint replacement surgery of the hip or knee, or synovectomy of the wrist (table 1) . Each patient satisfied the diagnostic criteria of the American College of Rheumatology.'4 As a control, five synovial tissue samples were also obtained during joint replacement surgery for femoral neck fracture; fracture samples showing inflammatory synovitis on histopathological examination were excluded from the analysis. All patients with RA were treated with disease modifying antirheumatic drugs (DMARDs), and eight patients with active RA were receiving low dose prednisone (less than Bcl-2   1  3  2  0  2  3  1  1  1  2  4  2  0  2  3   1  1  1   3  3  2  0  0  1  1  1  0  4  3  3  0  1  1  0  2  1  5  3  3  0  1  2   1   2  1  6  3  2  0  1  2  1  1   1  7  4  1  1  1  2   1   1  1  8  4  3  0  2  2  1  2  2  9 fig 1A) , but the ISNEL positive synovial cells in the sample from patient 11 were clustered in a section of the papillary proliferated synovial lining layer ( fig 1B) . The most superficial synoviocytes just separating from their origin also stained with ISNEL. In these areas, we were able to identify several cells with apoptosis specific morphological changes such as halo ring formation, chromosomal condensation, nuclear fragmentation, and eosinophilic change of the cytoplasm (fig 1 C) layer (fig 3A) . The synovial lining cells in certain regions were also positive, but their immunoreactivity was much weaker than that of the sublining cells. There was no relationship between the distribution of p2 1wAF1/cIP1 and the scoring of histological findings. Staining with p2lWIAF/CIPl was also identified in all but one normal subject with weak immunoreactivity (data not shown).
Staining for p53 and c-myc was observed in 10 and eight RA samples, respectively, while no immunoreactivity to these molecules was observed in normal subjects. Immunoreactivity to p53 and c-myc was seen only in the cytoplasm of the sublining cells; synovial lining cells and infiltrated lymphocytes did not react with these antibodies (fig 3B and C,  respectively) . The expression of these proteins was also unrelated to the degree of synovial proliferation and lymphocyte infiltration. Although fewer cells stained with p53 or c-myc than with p2 IwAF"c'P, p53 and c-myc proteins seemed often to be expressed simultaneously with p2 Fll"'Pl. We therefore double stained sections that had stained with p2 I wAF"cpl or c-myc, using p53 antibody, and found that a large number of cells stained with p2 l"'c"F or c-myc did not react with p53 antibody, though substantial numbers of cells were double stained ( fig 2B, and data not shown) . When p53 positive slides were double stained with CD68 to investigate whether p53 positive cells containing large amounts of cytoplasm were derived from macrophages, CD68 positive cells did not always coincide with p53 positive cells ( fig 2C) .
Staining for PCNA was observed in the synovial lining cell layers with intranuclear staining of both normal and RA samples. PCNA positive synovial cells were distributed sparsely in normal subjects, while they tended to cluster within certain areas of the hypertrophic synovial lining layer in RA samples ( fig  3D) . Neither sublining cells nor infiltrated lymphocytes stained with PCNA.
Immunoreactivity against Bcl-2 was readily identifiable in nine RA synovia, while synovial cells of normal subjects did not react with this antibody. Intense cytoplasmic staining for Bcl-2 was observed mainly in lymphocytes forming lymphoid follicles and in sparsely infiltrated segments (fig 4) . In addition, a substantial number of the sublining and stromal cells within the lymphoid follicles also showed faint but distinct immunoreactivity. In Our findings confirm those of previous studies23 demonstrating that the Bcl-2 protein was expressed particularly in infiltrated lymphocytes and in some RA synovial sublining cells in which apoptosis was not pronounced. As Bcl-2 acts as an inhibitor of apoptosis through the antioxidant pathway,36 37 synovial cells expressing Bcl-2 may resist apoptosis in response to a number of stimuli. Such stimulation may be triggered by several factors, such as cytokines, free radicals, and nitrogen oxide, present at high levels in RA synovial fluid. 38 In this regard, our finding that infiltrated lymphocytes did not undergo apoptosis may support an earlier hypothesis implicating failure of B cell death in the pathogenesis of RA.39 Although we did not identify the phenotype of infiltrated lymphocytes, overexpression of Bcl-2 protein may increase the threshold for apoptosis, thus playing a key part in controlling the proportion of cells in the RA synovium.Y Further studies are necessary to verify this assumption.
Considered together, our findings suggest that apoptosis can occur in RA synovial cells, but its frequency is extremely low compared with previous reports. We consider that apoptosis of the synovial tissue may tend to be suppressed by overexpression of Bcl-2, and that proliferated synovial tissue in RA may, indeed, fail to trigger apoptosis because it expresses Bcl-2. Although no significant relationship was found in the present study between apoptosis and disease duration or activity, it is possible that apoptosis may have a key role in synovial cell death occurring during the natural history of RA, and that it may be responsible for rice body formation or the disappearance of proliferated synovium in the late remission phase.
